298 related articles for article (PubMed ID: 24206395)
21. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
Bishop AC; Zhang XY; Lone AM
Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
[TBL] [Abstract][Full Text] [Related]
22. Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B.
Andersen HS; Olsen OH; Iversen LF; Sørensen AL; Mortensen SB; Christensen MS; Branner S; Hansen TK; Lau JF; Jeppesen L; Moran EJ; Su J; Bakir F; Judge L; Shahbaz M; Collins T; Vo T; Newman MJ; Ripka WC; Møller NP
J Med Chem; 2002 Sep; 45(20):4443-59. PubMed ID: 12238924
[TBL] [Abstract][Full Text] [Related]
23. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
[TBL] [Abstract][Full Text] [Related]
24. Rational design of selective organoruthenium inhibitors of protein tyrosine phosphatase 1B.
Ong JX; Yap CW; Ang WH
Inorg Chem; 2012 Nov; 51(22):12483-92. PubMed ID: 23121648
[TBL] [Abstract][Full Text] [Related]
25. Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor.
Liu GX; Tan JZ; Niu CY; Shen JH; Luo XM; Shen X; Chen KX; Jiang HL
Acta Pharmacol Sin; 2006 Jan; 27(1):100-10. PubMed ID: 16364216
[TBL] [Abstract][Full Text] [Related]
26. Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases.
Iversen LF; Andersen HS; Møller KB; Olsen OH; Peters GH; Branner S; Mortensen SB; Hansen TK; Lau J; Ge Y; Holsworth DD; Newman MJ; Hundahl Møller NP
Biochemistry; 2001 Dec; 40(49):14812-20. PubMed ID: 11732900
[TBL] [Abstract][Full Text] [Related]
27. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite.
Takakura K; Beckman JS; MacMillan-Crow LA; Crow JP
Arch Biochem Biophys; 1999 Sep; 369(2):197-207. PubMed ID: 10486138
[TBL] [Abstract][Full Text] [Related]
28. Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 Phosphatases.
Dong J; Jassim BA; Milholland KL; Qu Z; Bai Y; Miao Y; Miao J; Ma Y; Lin J; Hall MC; Zhang ZY
J Med Chem; 2024 Jun; 67(11):8817-8835. PubMed ID: 38768084
[TBL] [Abstract][Full Text] [Related]
29. Discovery and SAR of novel, potent and selective protein tyrosine phosphatase 1B inhibitors.
Pei Z; Li X; Liu G; Abad-Zapatero C; Lubben T; Zhang T; Ballaron SJ; Hutchins CW; Trevillyan JM; Jirousek MR
Bioorg Med Chem Lett; 2003 Oct; 13(19):3129-32. PubMed ID: 12951078
[TBL] [Abstract][Full Text] [Related]
30. A gatekeeper residue for inhibitor sensitization of protein tyrosine phosphatases.
Bishop AC; Blair ER
Bioorg Med Chem Lett; 2006 Aug; 16(15):4002-6. PubMed ID: 16716588
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for inhibition of protein tyrosine phosphatases by Keggin compounds phosphomolybdate and phosphotungstate.
Heo YS; Ryu JM; Park SM; Park JH; Lee HC; Hwang KY; Kim J
Exp Mol Med; 2002 Jul; 34(3):211-23. PubMed ID: 12216113
[TBL] [Abstract][Full Text] [Related]
32. Peptidomimetic competitive inhibitors of protein tyrosine phosphatases.
Shen K; Qi L; Stiff L
Curr Pharm Des; 2010; 16(28):3101-17. PubMed ID: 20687872
[TBL] [Abstract][Full Text] [Related]
33. Inhibitors for proteins endowed with catalytic and non-catalytic activity which recognize pTyr.
Costantino L; Barlocco D
Curr Med Chem; 2004 Oct; 11(20):2725-47. PubMed ID: 15544473
[TBL] [Abstract][Full Text] [Related]
34. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry.
Tan LP; Wu H; Yang PY; Kalesh KA; Zhang X; Hu M; Srinivasan R; Yao SQ
Org Lett; 2009 Nov; 11(22):5102-5. PubMed ID: 19852491
[TBL] [Abstract][Full Text] [Related]
35. Structure-based optimization of benzoic acids as inhibitors of protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase.
Maccari R; Ottanà R; Ciurleo R; Paoli P; Manao G; Camici G; Laggner C; Langer T
ChemMedChem; 2009 Jun; 4(6):957-62. PubMed ID: 19288492
[TBL] [Abstract][Full Text] [Related]
36. Protein tyrosine phosphatase inhibitors: a patent review (2002 - 2011).
Sobhia ME; Paul S; Shinde R; Potluri M; Gundam V; Kaur A; Haokip T
Expert Opin Ther Pat; 2012 Feb; 22(2):125-53. PubMed ID: 22332719
[TBL] [Abstract][Full Text] [Related]
37. 5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases.
Maccari R; Paoli P; Ottanà R; Jacomelli M; Ciurleo R; Manao G; Steindl T; Langer T; Vigorita MG; Camici G
Bioorg Med Chem; 2007 Aug; 15(15):5137-49. PubMed ID: 17543532
[TBL] [Abstract][Full Text] [Related]
38. Discovery of potent, selective and orally bioavailable triaryl-sulfonamide based PTP1B inhibitors.
Patel D; Jain M; Shah SR; Bahekar R; Jadav P; Joharapurkar A; Dhanesha N; Shaikh M; Sairam KV; Kapadnis P
Bioorg Med Chem Lett; 2012 Jan; 22(2):1111-7. PubMed ID: 22189136
[TBL] [Abstract][Full Text] [Related]
39. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
40. Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases.
Hendriks W; Bourgonje A; Leenders W; Pulido R
Molecules; 2018 Feb; 23(2):. PubMed ID: 29439552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
